JP2008280351A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008280351A5 JP2008280351A5 JP2008158153A JP2008158153A JP2008280351A5 JP 2008280351 A5 JP2008280351 A5 JP 2008280351A5 JP 2008158153 A JP2008158153 A JP 2008158153A JP 2008158153 A JP2008158153 A JP 2008158153A JP 2008280351 A5 JP2008280351 A5 JP 2008280351A5
- Authority
- JP
- Japan
- Prior art keywords
- solid
- preparation according
- solid preparation
- terbinafine
- taste
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007787 solid Substances 0.000 claims 15
- 238000002360 preparation method Methods 0.000 claims 11
- DOMXUEMWDBAQBQ-WEVVVXLNSA-N terbinafine Chemical compound C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 DOMXUEMWDBAQBQ-WEVVVXLNSA-N 0.000 claims 6
- 229960002722 terbinafine Drugs 0.000 claims 6
- 239000011248 coating agent Substances 0.000 claims 5
- 238000000576 coating method Methods 0.000 claims 5
- 239000003795 chemical substances by application Substances 0.000 claims 4
- 239000008185 minitablet Substances 0.000 claims 3
- 208000010470 Ageusia Diseases 0.000 claims 2
- 206010013911 Dysgeusia Diseases 0.000 claims 2
- 230000002411 adverse Effects 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 239000008188 pellet Substances 0.000 claims 2
- 229920000058 polyacrylate Polymers 0.000 claims 2
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims 1
- 229920003134 Eudragit® polymer Polymers 0.000 claims 1
- 206010017533 Fungal infection Diseases 0.000 claims 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical group COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 claims 1
- 208000031888 Mycoses Diseases 0.000 claims 1
- 208000010195 Onychomycosis Diseases 0.000 claims 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims 1
- 239000013543 active substance Substances 0.000 claims 1
- 235000019666 ageusia Nutrition 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 239000001913 cellulose Substances 0.000 claims 1
- 229920002678 cellulose Polymers 0.000 claims 1
- 239000007979 citrate buffer Substances 0.000 claims 1
- 239000008119 colloidal silica Substances 0.000 claims 1
- 230000037406 food intake Effects 0.000 claims 1
- 239000007903 gelatin capsule Substances 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 230000000873 masking effect Effects 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000002245 particle Substances 0.000 claims 1
- 239000002243 precursor Substances 0.000 claims 1
- 210000002784 stomach Anatomy 0.000 claims 1
- 201000005882 tinea unguium Diseases 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0117760A GB0117760D0 (en) | 2001-07-20 | 2001-07-20 | Organic compounds |
| GB0128993A GB0128993D0 (en) | 2001-12-04 | 2001-12-04 | Organic compounds |
| GB0212209A GB0212209D0 (en) | 2002-05-27 | 2002-05-27 | Organic compounds |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003526396A Division JP2005503399A (ja) | 2001-07-20 | 2002-07-19 | テルビナフィンを含有する医薬組成物およびその使用 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012020039A Division JP2012136523A (ja) | 2001-07-20 | 2012-02-01 | テルビナフィンを含有する医薬組成物およびその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008280351A JP2008280351A (ja) | 2008-11-20 |
| JP2008280351A5 true JP2008280351A5 (enExample) | 2009-04-23 |
Family
ID=27256227
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003526396A Withdrawn JP2005503399A (ja) | 2001-07-20 | 2002-07-19 | テルビナフィンを含有する医薬組成物およびその使用 |
| JP2008158153A Pending JP2008280351A (ja) | 2001-07-20 | 2008-06-17 | テルビナフィンを含有する医薬組成物およびその使用 |
| JP2012020039A Pending JP2012136523A (ja) | 2001-07-20 | 2012-02-01 | テルビナフィンを含有する医薬組成物およびその使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003526396A Withdrawn JP2005503399A (ja) | 2001-07-20 | 2002-07-19 | テルビナフィンを含有する医薬組成物およびその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012020039A Pending JP2012136523A (ja) | 2001-07-20 | 2012-02-01 | テルビナフィンを含有する医薬組成物およびその使用 |
Country Status (27)
| Country | Link |
|---|---|
| US (2) | US20040198838A1 (enExample) |
| EP (1) | EP1411921B2 (enExample) |
| JP (3) | JP2005503399A (enExample) |
| KR (2) | KR100699958B1 (enExample) |
| CN (1) | CN100358518C (enExample) |
| AR (1) | AR034813A1 (enExample) |
| AT (1) | ATE381329T1 (enExample) |
| AU (1) | AU2002321249B2 (enExample) |
| BR (1) | BR0211198A (enExample) |
| CA (1) | CA2453263C (enExample) |
| CY (1) | CY1107861T1 (enExample) |
| DE (1) | DE60224194T3 (enExample) |
| DK (1) | DK1411921T4 (enExample) |
| ES (1) | ES2295381T5 (enExample) |
| HU (1) | HUP0401200A3 (enExample) |
| IL (2) | IL159591A0 (enExample) |
| MX (1) | MXPA04000627A (enExample) |
| MY (1) | MY136136A (enExample) |
| NO (1) | NO332268B1 (enExample) |
| NZ (1) | NZ530648A (enExample) |
| PE (1) | PE20030287A1 (enExample) |
| PL (1) | PL365416A1 (enExample) |
| PT (1) | PT1411921E (enExample) |
| RU (1) | RU2298402C2 (enExample) |
| SI (1) | SI1411921T2 (enExample) |
| TW (1) | TWI302460B (enExample) |
| WO (1) | WO2003022267A1 (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR034813A1 (es) † | 2001-07-20 | 2004-03-17 | Novartis Ag | Composiciones farmaceuticas y uso de las mismas |
| WO2004004700A1 (en) * | 2002-07-02 | 2004-01-15 | Novartis Ag | Methods for the treatment of sinusitis |
| JP2005060310A (ja) * | 2003-08-13 | 2005-03-10 | Towa Yakuhin Kk | 不快な味をマスキングする経口投与用製剤 |
| JP2005187339A (ja) * | 2003-12-24 | 2005-07-14 | Iwaki Seiyaku Co Ltd | 耐光性塩酸テルビナフィンフィルムコート錠 |
| JP4999297B2 (ja) * | 2005-08-10 | 2012-08-15 | 高田製薬株式会社 | 高含量塩酸テルビナフィン小型錠剤 |
| WO2007110753A2 (en) * | 2006-03-28 | 2007-10-04 | Wockhardt Ltd | Extended release dosage forms of metoprolol |
| CN1820744B (zh) * | 2006-04-04 | 2011-01-26 | 中国人民解放军军事医学科学院毒物药物研究所 | 磷酸奥司他韦颗粒剂及其制备方法 |
| AU2007242077B2 (en) * | 2006-04-26 | 2013-11-14 | Alphapharm Pty Ltd | Controlled release formulations comprising uncoated discrete unit(s) and an extended release matrix |
| KR20090015954A (ko) * | 2006-06-07 | 2009-02-12 | 노파르티스 아게 | 롤러 압축기를 사용하여 다중미립체를 제조하는 방법 |
| TWI468191B (zh) * | 2009-01-28 | 2015-01-11 | Novartis Ag | 有機化合物之調配物 |
| WO2010086727A1 (en) * | 2009-01-30 | 2010-08-05 | Galderma Pharma Sa | Stable compositions for nail onychomycosis treatment |
| CN102198111A (zh) * | 2011-06-17 | 2011-09-28 | 哈尔滨乐泰药业有限公司 | 一种抗真菌药物片剂的制备方法 |
| WO2013043143A1 (ru) * | 2011-09-21 | 2013-03-28 | Slyusar Viktor Timopheevich | Способ снижения лишнего веса |
| EP2822542A1 (en) * | 2012-03-07 | 2015-01-14 | Santarus, Inc. | Controlled-release solid dosage forms of mesalamine |
| KR102865751B1 (ko) * | 2016-03-15 | 2025-09-29 | 에이서 테라퓨틱스 인크. | 소듐 페닐부티레이트를 포함하는 맛우수한 조성물 및 그의 용도 |
| US11504687B2 (en) | 2016-10-11 | 2022-11-22 | Khalifa University of Science and Technology | Coated chloride salt particles and methods of making and using the same |
| FR3069545B1 (fr) * | 2017-07-27 | 2020-10-16 | Soc Dexploitation De Produits Pour Les Industries Chimiques Seppic | Composition d'enrobage exempte de dioxyde de titane |
| CN109833301A (zh) * | 2017-11-29 | 2019-06-04 | 天津市保灵动物保健品有限公司 | 一种犬猫用盐酸特比萘芬风味片及其制备工艺 |
| CN109925296B (zh) * | 2017-12-19 | 2021-09-07 | 四川济生堂药业有限公司 | 一种中药微丸的包衣方法 |
| CN112156078A (zh) * | 2020-11-11 | 2021-01-01 | 乐泰药业有限公司 | 一种盐酸特比萘芬片、其制备方法以及杂质与质量检测方法 |
| CN116887866A (zh) | 2020-12-03 | 2023-10-13 | 巴特尔纪念研究院 | 聚合物纳米颗粒和dna纳米结构组合物及用于非病毒递送的方法 |
| JP2024516108A (ja) | 2021-04-07 | 2024-04-12 | バテル・メモリアル・インスティテュート | 非ウイルス性担体を同定および使用するための迅速な設計、構築、試験、および学習技術 |
| CN115869273B (zh) * | 2022-10-31 | 2025-09-30 | 修正药业集团长春高新制药有限公司 | 一种盐酸特比萘芬片及其制备方法 |
| WO2025072751A1 (en) | 2023-09-29 | 2025-04-03 | Battelle Memorial Institute | Polymer nanoparticle compositions for in vivo expression of polypeptides |
| WO2025122954A1 (en) | 2023-12-08 | 2025-06-12 | Battelle Memorial Institute | Use of dna origami nanostructures for molecular information based data storage systems |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK62184D0 (da) † | 1984-02-10 | 1984-02-10 | Benzon As Alfred | Diffusionsovertrukket polydepotpraeparat |
| DE3572440D1 (en) * | 1984-06-19 | 1989-09-28 | Basf Ag | Gastro-resistant cylindrical pancreatine-microtablets |
| US4728512A (en) * | 1985-05-06 | 1988-03-01 | American Home Products Corporation | Formulations providing three distinct releases |
| US4894375A (en) * | 1986-09-29 | 1990-01-16 | Merck & Co., Inc. | Method of controlling mycotic infections and compositions therefor |
| UA18867A (uk) * | 1989-06-08 | 1997-12-25 | Ф.Хоффманн Ля Рош АГ | Похідhі аміhоалкілбеhзолу оба їх фармацевтичhо прийhятhі солі з кислотами |
| DE3937455A1 (de) * | 1989-11-10 | 1991-05-16 | Nordmark Arzneimittel Gmbh | Antacidatabletten |
| GB9111477D0 (en) * | 1991-05-29 | 1991-07-17 | Sandoz Ltd | Pharmaceutical composition |
| US5262172A (en) * | 1992-06-19 | 1993-11-16 | Digestive Care Inc. | Compositions of gastric acid-resistant microspheres containing buffered bile acids |
| US5234697A (en) * | 1992-06-22 | 1993-08-10 | Digestive Care Inc. | Compositions of gastric acid-resistant microspheres containing salts of bile acids |
| US5578304A (en) * | 1992-06-22 | 1996-11-26 | Digestive Care Inc. | Compositions of digestive enzymes and salts of bile acids and process for preparation thereof |
| US5415872A (en) * | 1992-06-22 | 1995-05-16 | Digestive Care Inc. | Compositions of gastric acid-resistant microspheres containing salts of bile acids |
| US5332727A (en) * | 1993-04-29 | 1994-07-26 | Birkmayer U.S.A. | Stable, ingestable and absorbable NADH and NADPH therapeutic compositions |
| WO1995016465A1 (en) * | 1993-12-14 | 1995-06-22 | Sandoz Ltd. | Pharmaceutical compositions containing alkyl polyoxyalkylene carboxylates |
| GB2290965A (en) * | 1994-07-11 | 1996-01-17 | Therapicon Srl | Multiple layer capsules for drugs |
| FR2722102B1 (fr) * | 1994-07-11 | 1996-08-23 | Cird Galderma | Utilisation de particules creuses deformables dans une composition cosmetique et/ou dermatologique, contenant des matieres grasses |
| NZ280065A (en) * | 1995-09-20 | 1998-04-27 | Apotex Inc | Preparation of n-alkyl-n-(1-naphthylmethyl)alk-2-en-4-ynylamine derivatives |
| FR2751878B1 (fr) * | 1996-07-30 | 1998-09-04 | Oreal | Utilisation dans une composition d'un extrait d'au moins une labiee |
| US5814230A (en) * | 1996-08-30 | 1998-09-29 | Willis; H. Craig | Apparatus and method for separation of solids from liquid |
| DE19637082A1 (de) * | 1996-09-12 | 1998-03-19 | Boehringer Mannheim Gmbh | Schnellzerfallende Pellets |
| FR2755011B1 (fr) * | 1996-10-31 | 1998-11-20 | Cird Galderma | Utilisation des inhibiteurs de l'activite de l'acide retinoique pour traiter les peaux sensibles et/ou les dommages aigus induits par les rayonnements u.v. |
| CA2277017C (en) * | 1997-01-06 | 2002-11-26 | Pfizer Inc. | Rapidly releasing and taste-masking pharmaceutical dosage form |
| US6342250B1 (en) * | 1997-09-25 | 2002-01-29 | Gel-Del Technologies, Inc. | Drug delivery devices comprising biodegradable protein for the controlled release of pharmacologically active agents and method of making the drug delivery devices |
| FR2771291B1 (fr) † | 1997-11-21 | 2000-02-25 | Ethypharm Lab Prod Ethiques | Spheroides, procede de preparation et compositions pharmaceutiques |
| DE19842753A1 (de) † | 1998-09-18 | 2000-03-23 | Bayer Ag | Agitationsunabhängige pharmazeutische Retardzubereitungen und Verfahren zu ihrer Herstellung |
| US8293277B2 (en) * | 1998-10-01 | 2012-10-23 | Alkermes Pharma Ireland Limited | Controlled-release nanoparticulate compositions |
| US6322819B1 (en) * | 1998-10-21 | 2001-11-27 | Shire Laboratories, Inc. | Oral pulsed dose drug delivery system |
| ES2601855T3 (es) * | 1998-11-25 | 2017-02-16 | Cima Labs Inc. | Comprimido de liberación rápida con núcleo recubierto que contiene el fármaco y capa circundante de enmascaramiento del sabor |
| US6740341B1 (en) * | 1998-11-25 | 2004-05-25 | Cima Labs Inc. | Taste masking rapid release coating system |
| JP2002535353A (ja) † | 1999-01-29 | 2002-10-22 | ロザン ファルマ ゲゼルシャフトミットベシュレンクテルハフツンク | 医薬品組成物 |
| US6248363B1 (en) * | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| US6267985B1 (en) * | 1999-06-30 | 2001-07-31 | Lipocine Inc. | Clear oil-containing pharmaceutical compositions |
| CN1116033C (zh) * | 1999-07-08 | 2003-07-30 | 齐鲁制药厂 | 一种治疗阴道炎的泡腾片剂及其制法 |
| TR200200313T2 (tr) * | 1999-08-17 | 2002-04-22 | Novartis Consumer Health S.A. | Hızla çözünen dozaj formu ve bunun yapım prosesi. |
| GB0001315D0 (en) * | 2000-01-20 | 2000-03-08 | Novartis Ag | Organic compounds |
| EP1257255A4 (en) † | 2000-02-24 | 2008-07-30 | Advancis Pharmaceutical Corp | THERAPEUTIC PRODUCT, ITS USE AND MANUFACTURE |
| DE10017996A1 (de) * | 2000-04-11 | 2001-10-18 | Pierre Foss | Lamisil-Intervall-System |
| GB0014448D0 (en) * | 2000-06-13 | 2000-08-09 | Novartis Ag | Organic compounds |
| AR034813A1 (es) † | 2001-07-20 | 2004-03-17 | Novartis Ag | Composiciones farmaceuticas y uso de las mismas |
| US20040198828A1 (en) * | 2003-01-17 | 2004-10-07 | Abelson Mark B. | Combinational use of long-acting and short-acting anti-histamines for ocular allergies |
-
2002
- 2002-07-18 AR ARP020102698A patent/AR034813A1/es unknown
- 2002-07-19 CN CNB028141040A patent/CN100358518C/zh not_active Expired - Fee Related
- 2002-07-19 KR KR1020067011980A patent/KR100699958B1/ko not_active Expired - Fee Related
- 2002-07-19 SI SI200230669T patent/SI1411921T2/sl unknown
- 2002-07-19 ES ES02754918T patent/ES2295381T5/es not_active Expired - Lifetime
- 2002-07-19 EP EP02754918A patent/EP1411921B2/en not_active Expired - Lifetime
- 2002-07-19 MX MXPA04000627A patent/MXPA04000627A/es active IP Right Grant
- 2002-07-19 DK DK02754918.7T patent/DK1411921T4/da active
- 2002-07-19 KR KR1020047000865A patent/KR100651110B1/ko not_active Expired - Fee Related
- 2002-07-19 CA CA2453263A patent/CA2453263C/en not_active Expired - Fee Related
- 2002-07-19 PL PL02365416A patent/PL365416A1/xx not_active Application Discontinuation
- 2002-07-19 PT PT02754918T patent/PT1411921E/pt unknown
- 2002-07-19 US US10/483,436 patent/US20040198838A1/en not_active Abandoned
- 2002-07-19 JP JP2003526396A patent/JP2005503399A/ja not_active Withdrawn
- 2002-07-19 BR BR0211198-5A patent/BR0211198A/pt not_active IP Right Cessation
- 2002-07-19 RU RU2004105263/15A patent/RU2298402C2/ru not_active IP Right Cessation
- 2002-07-19 AT AT02754918T patent/ATE381329T1/de active
- 2002-07-19 MY MYPI20022738A patent/MY136136A/en unknown
- 2002-07-19 NZ NZ530648A patent/NZ530648A/en not_active IP Right Cessation
- 2002-07-19 IL IL15959102A patent/IL159591A0/xx unknown
- 2002-07-19 DE DE60224194T patent/DE60224194T3/de not_active Expired - Lifetime
- 2002-07-19 HU HU0401200A patent/HUP0401200A3/hu unknown
- 2002-07-19 TW TW091116154A patent/TWI302460B/zh not_active IP Right Cessation
- 2002-07-19 AU AU2002321249A patent/AU2002321249B2/en not_active Ceased
- 2002-07-19 WO PCT/EP2002/008095 patent/WO2003022267A1/en not_active Ceased
- 2002-07-22 PE PE2002000645A patent/PE20030287A1/es not_active Application Discontinuation
-
2003
- 2003-12-25 IL IL159591A patent/IL159591A/en not_active IP Right Cessation
-
2004
- 2004-01-19 NO NO20040254A patent/NO332268B1/no not_active IP Right Cessation
-
2008
- 2008-01-18 CY CY20081100079T patent/CY1107861T1/el unknown
- 2008-06-17 JP JP2008158153A patent/JP2008280351A/ja active Pending
- 2008-07-18 US US12/218,806 patent/US20080286356A1/en not_active Abandoned
-
2012
- 2012-02-01 JP JP2012020039A patent/JP2012136523A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008280351A5 (enExample) | ||
| CA2453263A1 (en) | Pharmaceutical compositions containing terbinafine and use thereof | |
| JP2011509295A5 (enExample) | ||
| JP2016504384A5 (enExample) | ||
| HUP0302086A2 (hu) | Késleltetett hatású orális gyógyászati készítmény és eljárás az előállítására | |
| EP3154523A1 (en) | Formulation for oral administration containing mesalazine | |
| JP2010270124A5 (enExample) | ||
| WO2010127346A1 (en) | Orally disintegrating tablet compositions comprising combinations of non-opioid and opioid analgesics | |
| JP2007511510A (ja) | 持続放出性ベンラファキシン製剤 | |
| WO2011139044A2 (ko) | 탐스로신 또는 이의 약학적으로 허용 가능한 염을 포함하는 방출 제어용 약학 조성물, 및 이를 포함하는 경구용 제제 | |
| JP2012505884A5 (enExample) | ||
| KR102381586B1 (ko) | 메살라진의 경구용 약제학적 조성물 | |
| JP2016500088A5 (enExample) | ||
| JP2008519070A5 (enExample) | ||
| JP2009537611A5 (ja) | リポ酸のペレット | |
| JP2005503399A5 (enExample) | ||
| JP2019509345A5 (enExample) | ||
| JP2014533656A5 (enExample) | ||
| JP2010518088A5 (enExample) | ||
| JP2013508289A5 (enExample) | ||
| JP2024159885A (ja) | アマンタジン組成物、その調製、および使用方法 | |
| US20120093939A1 (en) | Oral formulations | |
| MD4622C1 (ro) | Minigranule cu eliberare prelungită a trimetazidinei | |
| JP2008519069A5 (enExample) | ||
| JP5715139B2 (ja) | 消化管に存在する望ましくない分子を特異的に吸着し得る医学製剤 |